The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 14 results:
Author Title [ Type(Desc)] Year
Filters: Author is Vlachaki, Efthimia  [Clear All Filters]
Journal Article
Hatzipantelis, E. S., Karasmanis K., Perifanis V., Vlachaki E., Tziomalos K., & Economou M. (2014).  Combined chelation therapy with deferoxamine and deferiprone in β-thalassemia major: compliance and opinions of young thalassemic patients.. Hemoglobin. 38(2), 111-4.
Vlachaki, E., Chatzinikolaou K., Bekiari E., Klonizakis F., & Tsapas A. (2011).  Is deferasirox implicated in multiple organ failure in a patient with homozygous β-thalassemia?. Angiology. 62(4), 346-8.
Sousos, N., Vlachaki E., Anastasiadou K., Boura P., Venizelos I., Chatzimavroudis G., et al. (2015).  Diffuse gastric plasmacytoma involvement in multiple myeloma.. Endoscopy. 47 Suppl 1 UCTN, E197.
Dimitriadou, M., Christoforidis A., Economou M., Tsatra I., Vlachaki E., Fidani L., et al. (2010).  Elevated serum parathormone levels are associated with myocardial iron overload in patients with beta-thalassaemia major.. Eur J Haematol. 84(1), 64-71.
Stratopoulos, A., Kolliopoulou A., Karamperis K., John A., Kydonopoulou K., Esftathiou G., et al. (2019).  Genomic variants in members of the Krüppel-like factor gene family are associated with disease severity and hydroxyurea treatment efficacy in β-hemoglobinopathies patients.. Pharmacogenomics. 20(11), 791-801.
Varelas, C., Gavriilaki E., Sakellari I., Klonizakis F., Anagnostopoulos A., Tsapas A., et al. (2022).  Hemoglobinopathies and COVID-19: The Experience of a Center in Northern Greece.. Hemoglobin. 46(2), 143-145.
Sinakos, E., Perifanis V., Vlachaki E., Tsatra I., & Raptopoulou-Gigi M. (2010).  Is liver stiffness really unrelated to liver iron concentration?. Br J Haematol. 150(2), 247-8.
Christoforidis, A., Perifanis V., Spanos G., Vlachaki E., Economou M., Tsatra I., et al. (2009).  MRI assessment of liver iron content in thalassamic patients with three different protocols: comparisons and correlations.. Eur J Haematol. 82(5), 388-92.
Vlachaki, E., Tsapas A., Dimitrakopoulos K., Kontzoglou G., & Klonizakis I. (2009).  Parotid gland oncocytoma: a case report.. Cases J. 2, 6423.
Christoforidis, A., Perifanis V., Papadopoulou E., Dimitriadou M., Kazantzidou E., Vlachaki E., et al. (2009).  Poor correlations between measurements of bone quality by quantitative ultrasound sonography and dual energy X-ray absorptiometry in patients with beta-thalassaemia major.. Eur J Haematol. 82(1), 15-21.
Bourli, E., Dimitriadou M., Economou M., Vlachaki E., Christoforidis A., Maratou E., et al. (2012).  Restrictive pulmonary dysfunction and its predictors in young patients with β-thalassaemia major.. Pediatr Pulmonol. 47(8), 801-7.
Paschos, P., Vlachaki E., Pasvanti C., Sinakos E., Kalpaka A., Klonizakis P., et al. (2011).  Safety and efficacy of combination therapy with pegylated interferon alpha-2a and ribavirin in treating patients with chronic hepatitis C and beta-thalassaemia major: a Greek single-center experience.. Acta Haematol. 126(4), 231-3.
Sinakos, E., Vlachaki E., & Tsapas A. (2012).  Safety of deferasirox in sickle cell disease patients with co-existing liver impairment.. Br J Haematol. 157(4), 505-6; author reply 506-7.
Demosthenous, C., Eleftheriou P., Apostolou C., Sarafidis P., Perifanis V., & Vlachaki E. (2018).  β-Thalassemia and renal complications. A narrative review of pathophysiologic mechanisms. Integrative Molecular Medicine. 5(4), 

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.